|
|
-
Onyx Pharma And UCSF Helen Diller Family Comprehensive Cancer Center Announce Oncology Innovation Alliance
6/3/2013
|
|
|
-
Bayer HealthCare Pharma, Onyx Pharma Announce Positive Results From Phase 3 DECISION Trial Investigating Nexavar
6/2/2013
|
-
Barclays Capital Is Increasing Onyx Pharmaceuticals Inc. (ONXX) FY14 Estimate To 1.28 From 1.02
5/8/2013
|
-
Barclays Capital Is Increasing Onyx Pharmaceuticals Inc. (ONXX) FY13 Estimate To -1.58 From -2.67
5/8/2013
|
|
|
-
Onyx Pharma Q1 Non-GAAP Loss Per Share $0.19 Vs Loss $0.68 Last Year
5/7/2013
|
|
|
|
|